Published in Biotech Business Week, May 9th, 2005
Dr. Baron L. Hamman, cardiothoracic surgeon, performed a series of U.S. clinical cases recently at Baylor University Medical Center in Dallas, Texas. The three patients presented with chronic atrial fibrillation (AF), mitral valve and coronary artery disease. The AtriLaze surgical ablation procedures were performed as concomitant procedures with mitral valve repair or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.